homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

March 11, 2020

NanoSurface Biomedical

Seattle biotechnology company NanoSurface Biomedical received $1.9 million in funding from the National Institutes of Health for development of stem cell-based platforms that help pharmaceutical companies accelerate drug development. NanoSurface previously received $1.2 million from NIH.




Email or user name:
Password:
 
Forgot password? Click here.